Class information for: |
Basic class information |
Hierarchy of classes |
The table includes all classes above and classes immediately below the current class. |
Cluster id | Level | Cluster label | #P |
---|---|---|---|
0 | 4 | ONCOLOGY//CELL BIOLOGY//BIOCHEMISTRY & MOLECULAR BIOLOGY | 2934640 |
234 | 3 | GYNECOLOGIC ONCOLOGY//GYNECOL ONCOL//OVARIAN CANCER | 48422 |
1441 | 2 | CA 125//CA 19 9//HE4 | 8114 |
3440 | 1 | CA 125//HE4//CA125 | 2016 |
6428 | 1 | CEACAM1//BILIARY GLYCOPROTEIN//CEACAM6 | 1513 |
8080 | 1 | CA 19 9//CA 242//CA 72 4 | 1318 |
9170 | 1 | CARCINOEMBRYONIC ANTIGEN//CEA//SYNCHRONOUS COLORECTAL CANCER | 1212 |
11994 | 1 | CA 15 3//TISSUE POLYPEPTIDE SPECIFIC ANTIGEN//CA 549 | 967 |
12516 | 1 | ANTI P53 ANTIBODIES//SERUM P53 ANTIBODY//P53 ANTIBODIES | 931 |
32047 | 1 | GEL FIBERGLASS//TERATOL EXPT ONCOL//TUMOR ASSOCIATED ANTIGENS P66 AND P51 | 157 |
Terms with highest relevance score |
rank | Category | termType | chi_square | shrOfCwithTerm | shrOfTermInClass | termInClass |
---|---|---|---|---|---|---|
1 | CA 125 | authKW | 695186 | 5% | 46% | 393 |
2 | CA 19 9 | authKW | 660236 | 4% | 48% | 357 |
3 | HE4 | authKW | 594187 | 2% | 86% | 178 |
4 | CA125 | authKW | 490959 | 3% | 45% | 281 |
5 | CA 15 3 | authKW | 489439 | 3% | 62% | 204 |
6 | CEA | authKW | 449683 | 4% | 33% | 356 |
7 | TUMOR MARKER | authKW | 442051 | 8% | 18% | 635 |
8 | CARCINOEMBRYONIC ANTIGEN | authKW | 356231 | 5% | 25% | 374 |
9 | CEACAM1 | authKW | 278253 | 1% | 80% | 90 |
10 | HUMAN EPIDIDYMIS PROTEIN 4 | authKW | 194399 | 1% | 96% | 52 |
Web of Science journal categories |
chi_square_rank | Category | chi_square | shrOfCwithTerm | shrOfTermInClass | termInClass |
---|---|---|---|---|---|
1 | Oncology | 56072 | 43% | 0% | 3527 |
2 | Obstetrics & Gynecology | 11304 | 12% | 0% | 965 |
3 | Medical Laboratory Technology | 6030 | 5% | 0% | 384 |
4 | Gastroenterology & Hepatology | 3811 | 7% | 0% | 578 |
5 | Surgery | 2288 | 11% | 0% | 897 |
6 | Pathology | 974 | 4% | 0% | 302 |
7 | Reproductive Biology | 921 | 2% | 0% | 197 |
8 | Medicine, Research & Experimental | 581 | 4% | 0% | 357 |
9 | Medicine, General & Internal | 477 | 5% | 0% | 429 |
10 | Immunology | 305 | 5% | 0% | 394 |
Address terms |
chi_square_rank | term | chi_square | shrOfCwithTerm | shrOfTermInClass | termInClass |
---|---|---|---|---|---|
1 | HENAN TUMOR EPIDEMIOL | 21489 | 0% | 46% | 12 |
2 | TERATOL EXPT ONCOL | 20700 | 0% | 67% | 8 |
3 | ONCIMMUNE LTD | 17467 | 0% | 75% | 6 |
4 | SURG BIOL | 16175 | 0% | 83% | 5 |
5 | IMMUNOCHEM GLYCOBIOL | 13972 | 0% | 60% | 6 |
6 | CNR IBPM | 12675 | 0% | 47% | 7 |
7 | BIOMARKERS EMERGING TECHNOL | 12422 | 0% | 80% | 4 |
8 | STOLLER BIOMARKER DISCOVERY PATHOL NODE | 11647 | 0% | 100% | 3 |
9 | KORET VET MED | 10381 | 1% | 6% | 49 |
10 | EXCELLENCE AUTOIMMUN CANC | 10350 | 0% | 67% | 4 |
Journals |
chi_square_rank | term | chi_square | shrOfCwithTerm | shrOfTermInClass | termInClass |
---|---|---|---|---|---|
1 | JOURNAL OF TUMOR MARKER ONCOLOGY | 23754 | 0% | 19% | 32 |
2 | INTERNATIONAL JOURNAL OF BIOLOGICAL MARKERS | 22480 | 1% | 8% | 74 |
3 | TUMOR BIOLOGY | 16842 | 2% | 3% | 174 |
4 | ANTICANCER RESEARCH | 16258 | 4% | 1% | 289 |
5 | GYNECOLOGIC ONCOLOGY | 14249 | 3% | 2% | 208 |
6 | JOURNAL OF NUCLEAR MEDICINE AND ALLIED SCIENCES | 13966 | 0% | 10% | 35 |
7 | TUMORDIAGNOSTIK & THERAPIE | 13937 | 1% | 7% | 53 |
8 | TUMORDIAGNOSTIK | 9770 | 0% | 23% | 11 |
9 | BRITISH JOURNAL OF CANCER | 7173 | 2% | 1% | 187 |
10 | CANCER DETECTION AND PREVENTION | 6540 | 1% | 3% | 52 |
Author Key Words |
chi_square_rank | term | chi_square | shrOfCwithTerm | shrOfTermInClass | termInClass | LCSH search | Wikipedia search |
---|---|---|---|---|---|---|---|
1 | CA 125 | 695186 | 5% | 46% | 393 | Search CA+125 | Search CA+125 |
2 | CA 19 9 | 660236 | 4% | 48% | 357 | Search CA+19+9 | Search CA+19+9 |
3 | HE4 | 594187 | 2% | 86% | 178 | Search HE4 | Search HE4 |
4 | CA125 | 490959 | 3% | 45% | 281 | Search CA125 | Search CA125 |
5 | CA 15 3 | 489439 | 3% | 62% | 204 | Search CA+15+3 | Search CA+15+3 |
6 | CEA | 449683 | 4% | 33% | 356 | Search CEA | Search CEA |
7 | TUMOR MARKER | 442051 | 8% | 18% | 635 | Search TUMOR+MARKER | Search TUMOR+MARKER |
8 | CARCINOEMBRYONIC ANTIGEN | 356231 | 5% | 25% | 374 | Search CARCINOEMBRYONIC+ANTIGEN | Search CARCINOEMBRYONIC+ANTIGEN |
9 | CEACAM1 | 278253 | 1% | 80% | 90 | Search CEACAM1 | Search CEACAM1 |
10 | HUMAN EPIDIDYMIS PROTEIN 4 | 194399 | 1% | 96% | 52 | Search HUMAN+EPIDIDYMIS+PROTEIN+4 | Search HUMAN+EPIDIDYMIS+PROTEIN+4 |
Core articles |
The table includes core articles in the class. The following variables is taken into account for the relevance score of an article in a cluster c: (1) Number of references referring to publications in the class. (2) Share of total number of active references referring to publications in the class. (3) Age of the article. New articles get higher score than old articles. (4) Citation rate, normalized to year. |
Classes with closest relation at Level 2 |